GUIDO, MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 4.955
AS - Asia 2.296
EU - Europa 1.949
SA - Sud America 472
Continente sconosciuto - Info sul continente non disponibili 185
AF - Africa 46
OC - Oceania 3
Totale 9.906
Nazione #
US - Stati Uniti d'America 4.838
SG - Singapore 1.279
RU - Federazione Russa 636
IE - Irlanda 576
BR - Brasile 389
CN - Cina 296
HK - Hong Kong 284
VN - Vietnam 188
DE - Germania 180
IT - Italia 175
GB - Regno Unito 73
CA - Canada 65
FI - Finlandia 58
IN - India 56
FR - Francia 47
JP - Giappone 33
AR - Argentina 31
BD - Bangladesh 30
SE - Svezia 29
CZ - Repubblica Ceca 27
PL - Polonia 26
MX - Messico 25
NL - Olanda 24
BE - Belgio 19
ES - Italia 19
IQ - Iraq 18
EC - Ecuador 14
ID - Indonesia 13
TR - Turchia 12
ZA - Sudafrica 12
AT - Austria 10
CO - Colombia 10
KR - Corea 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
SA - Arabia Saudita 8
VE - Venezuela 8
LT - Lituania 7
MA - Marocco 7
NP - Nepal 7
BG - Bulgaria 6
EG - Egitto 6
OM - Oman 6
PK - Pakistan 6
TN - Tunisia 6
AZ - Azerbaigian 5
CR - Costa Rica 5
IL - Israele 5
JM - Giamaica 5
UY - Uruguay 5
AL - Albania 4
BO - Bolivia 4
EE - Estonia 4
TT - Trinidad e Tobago 4
UA - Ucraina 4
UZ - Uzbekistan 4
AU - Australia 3
KE - Kenya 3
KG - Kirghizistan 3
KZ - Kazakistan 3
PH - Filippine 3
RO - Romania 3
RS - Serbia 3
TW - Taiwan 3
BS - Bahamas 2
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
IR - Iran 2
LB - Libano 2
MK - Macedonia 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
PT - Portogallo 2
TH - Thailandia 2
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
GA - Gabon 1
GE - Georgia 1
GL - Groenlandia 1
GM - Gambi 1
GQ - Guinea Equatoriale 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KH - Cambogia 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MT - Malta 1
MW - Malawi 1
NG - Nigeria 1
Totale 9.711
Città #
Dallas 710
Singapore 671
San Jose 576
Dublin 568
Chandler 556
Ashburn 385
Santa Clara 281
Hong Kong 280
The Dalles 142
Jacksonville 141
Boardman 133
Council Bluffs 123
New York 118
Moscow 106
Los Angeles 104
Lawrence 82
Princeton 82
Wilmington 81
Des Moines 71
Columbus 69
Ho Chi Minh City 67
Munich 66
Beijing 60
Falkenstein 57
San Mateo 47
Ann Arbor 37
Hanoi 37
Falls Church 34
Rome 33
Tokyo 32
Lauterbourg 30
São Paulo 29
Orem 26
Helsinki 25
Warsaw 25
Frankfurt am Main 22
Toronto 20
Brno 19
Brussels 19
Montreal 19
Chennai 17
L’Aquila 17
Turku 17
Denver 16
Poplar 16
Atlanta 15
Chicago 15
San Francisco 15
Stockholm 15
Amsterdam 14
Lappeenranta 14
Hefei 13
Mumbai 13
Brasília 12
Brooklyn 12
Norwalk 12
Shanghai 12
Da Nang 11
Manchester 11
Milan 11
Phoenix 11
Boston 10
Curitiba 10
London 10
Seoul 10
Assago 9
Belo Horizonte 9
Bremen 9
Rio de Janeiro 9
Haiphong 8
Johannesburg 8
Ravenna 8
Baghdad 7
Buffalo 7
Charlotte 7
Düsseldorf 7
Hanover 7
Houston 7
Quito 7
Seattle 7
Gioiosa Ionica 6
Jakarta 6
Mexico City 6
Pittsburgh 6
Vienna 6
Ankara 5
Baku 5
Betim 5
Bristol 5
Bắc Ninh 5
Campinas 5
Montevideo 5
Olomouc 5
Pune 5
Raleigh 5
Sofia 5
St Louis 5
Birmingham 4
Cleveland 4
Erbil 4
Totale 6.530
Nome #
"Evaluation of extracellular vesicle-associated TGF-β as a biomarker in patients with endometriosis" in Meeting abstracts of the 3° EVIta symposium 150
Factors associated with chronic pelvic pain in women with endometriosis: A national study on clinical and sociodemographic characteristics, lifestyles, quality of life, and perceptions of quality of care, during the COVID-19 pandemic 149
Case report: incomplete Cauda Equina Syndrome following a caesarean section with spinal anaesthesia 145
ROLE OF VOCAL DISTRACTION ANALGESIA ON PAIN MANAGEMENT IN THE OFFICE HYSTEROSCOPY PROCEDURE: A RANDOMIZED CONTROLLED STUDY 144
Sex ratio at birth: causes of variation and narrative review of literature 142
Investigating Unhealthy Behaviors Associated with SF-36 Domains in Women with Endometriosis—Findings from a Web-Based Survey Data Set 139
Perinatal mental illness and autoimmune diseases: a qualitative sistematic review 139
Recurrent Metastatic Pulmonary Synovial Sarcoma during Pregnancy: A Case Report and Literature Review 133
Haemorrhoidal disease in pregnancy: results from a self-assessment questionnaire administered by means of a social network 133
The Impact of Metal Nanoparticles on Female Reproductive System: Risks and Opportunities 130
AGEs-related dysfunctions in PCOS: evidence from animal and clinical research 128
A first stage placental site trophoblastic tumor: a case report and review of literature 128
Acute insulin response to intravenous glucagon in polycystic ovary syndrome 126
Sonographic features of pelvic tuberculosis mimicking ovarian-tubal-peritoneal carcinoma 121
Synchronous ovarian and uterine tumours, case report of an unusual association 116
Pre-eclampsia: From Etiology and Molecular Mechanisms to Clinical Tools. A Review of the Literature 113
The Accuracy of Third-Trimester Ultrasound in Predicting Large for Gestational Age or Macrosomic Fetuses in Diabetic and Non-Diabetic Pregnant Women: A Systematic Review and Meta-Analysis 113
Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: Relationship with insulin secretion 113
Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndrome 112
Asymptomatic postmenopausal endometrial thickening: a comparison between transvaginal ultrasound and hysteroscopy in the diagnosis of intracavitary uterine pathologies 110
Second stimulation in the same ovarian cycle: an option to fully-personalize the treatment in poor prognosis patients undergoing PGT-A 108
Botulinum toxin in incontinent women with neurogenic bladder after failure with anticholinergic therapy, long-term results: a pilot study 107
Ultrasound Features and Clinical Outcome of Patients with Ovarian Masses Diagnosed during Pregnancy: Experience of Single Gynecological Ultrasound Center 105
The Perception of the Quality of Professional Healthcare Assistance for the Management of Endometriosis: Findings from a National Survey in Italy 105
Risk Assessment Model for Complications in Minimally Invasive Hysterectomy: A Pilot Study 102
Carbon dioxide in office diagnostic hysteroscopy: An open question. A multicenter randomized trial on 1982 procedures 101
Late third trimester diagnosis of congenital giant hemangioma complicated by the Kasabach-Merritt phenomen: a case report and literature review 101
Conservative Management and Ultrasound Follow-Up of Parasitic Myoma: Our Experience and Literature Review 98
Role of opioid antagonists in the treatment of women with glucoregulation abnormalities 98
Sonographic characteristics of ovarian Leydig cell tumor 94
The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome 93
COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine 93
The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study 92
Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome 92
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: A pilot prospective study 91
How should the best human embryo in vitro be? Current and future challenges for embryo selection 90
The accuracy of prenatal cell-free DNA screening for sex chromosome abnormalities: a systematic review and meta-analysis 90
Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase 90
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 89
A pilot study of the long-term effects of acipimox in polycystic ovarian syndrome 88
Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin 88
Effect of corticotropin-releasing factor on the pituitary-ovary axis in human luteal phase 88
The Italian guidelines on non-invasive and invasive prenatal diagnosis: Executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology (SIGO) 87
Using a 16-french resectoscope as an alternative device in the treatment of uterine lesions: A randomized controlled trial 87
Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study 86
Clinical efficacy andmetabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: A randomized study 86
The effect of age on the ovarian response to gonadotropin and on pregnancy rate in polycystic ovary syndrome 86
Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study 86
Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles 85
Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome 85
Vaginal mesh exposure after laparoscopic sacrocervicopexy performed with permanent or absorbable sutures 85
Conservative management of preterm premature rupture of membranes < 30 weeks of gestational age: Effectiveness of clinical guidelines implementation strategies 84
Comparison of absorbable and permanent sutures for laparoscopic sacrocervicopexy: A randomized controlled trial 84
Ethinylestradio-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: Evaluation of the metabolic impact 84
Effect of metformin on the growth hormone response to growth hormone-releasing hormone in obese women with polycystic ovary syndrome 84
Erratum: Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles (Fertility and Sterility (1994) 62 (35- 41)) 84
Laparoscopic sacrocolpopexy versus pelvic organ prolapse suspension for surgical management of pelvic organ prolapse: a retrospective study 84
How metformin acts in PCOS pregnant women: Insights into insulin secretion and peripheral action at each trimester of gestation 83
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? 83
Metformin improves endothelial function in normoinsulinemic PCOS patients: A new prospective 82
Tertiary Cytoreduction for Isolated Lymphnode Recurrence (ILNR) Ovarian Cancer in a BRCA2 Mutated Patient: Our Experience and Prevalence of BRCA 1 or 2 Genes Mutational Status in ILNR 81
Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome 81
Perimesencephalic Subarachnoid Hemorrhage in Pregnancy 81
Giant rapidly involuting congenital haemangioma and Kasabach-Merritt phenomenon: A potentially underhanded trap 80
The Impact of Thyroid Function on Human Reproduction: A Comprehensive Mini-Review 80
Opioid blockade effect on insulin β-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus 80
Follicular loss in endoscopic surgery for ovarian endometriosis: Quantitative and qualitative observations 80
DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer 79
Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome: Dexamethasone and GnRH-agonist administration 79
Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: Role of hyperinsulinism 79
Assessment of insulin resistance in lean women with polycystic ovary syndrome 79
Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: Effect of naloxone 78
Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome 77
Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome 77
Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome 77
Position paper on prevention of surgical site infections in obstetric and gynecological surgery 77
Endocrinology: Effect of opioid blockade on insulin metabolism in polycystic ovarian disease 76
Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome 76
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: A clinical, endocrinological, metabolic pilot study 76
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: A randomized double-blind placebocontrolled clinical trial 76
Differentiation of spermatogenic cells during in-vitro culture of testicular biopsy samples from patients with obstructive azoospermia: Effect of recombinant follicle stimulating hormone 75
Fertility preservation methods in breast cancer 75
The I-KAPCAM-AI-Q: a novel instrument for evaluating health care providers’ AI awareness in Italy 73
Human spermatogenesis in vitro: Respective effects of follicle- stimulating hormone and testosterone on meiosis, spermiogenesis, and sertoli cell apoptosis 72
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology 72
Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: A case report 72
Metaphase‑II oocyte competence is unlinked to the gonadotrophins used for ovarian stimulation: a matched case–control study in women of advanced maternal age 71
Expectant management may reduce overtreatment in women affected by unexplained infertility confirmed by diagnostic laparoscopy 71
Hyperinsulinemia in PCOS. Possible role in the determination of the ovary response to gonadotrophins 71
Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome 71
Sexual Function following Laparoscopic versus Transvaginal Closure of the Vaginal Vault after Laparoscopic Hysterectomy: Secondary Analysis of a Randomized Trial by the Italian Society of Gynecological Endoscopy Using a Validated Questionnaire 71
Maternal and fetal outcomes of intraplacental choriocarcinoma complicated by fetomaternal hemorrhage: a systematic review 70
The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes 70
Favorable conception and pregnancy involving a male patient affected by chronic myeloid leukemia while taking dasatinib 70
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease 69
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome 69
Metformin treatment does not affect total leptin levels and free leptin index in obese patients with polycystic ovary syndrome 69
The use of different size-hysteroscope in office hysteroscopy: Our experience 68
The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: An euglycaemic-hyperinsulinaemic clamp study 67
Nerve-Sparing Laparoscopic Colposacropexy Using a Percutaneous Surgical System: A Case Report 67
Totale 9.194
Categoria #
all - tutte 49.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.813


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022421 0 0 3 9 32 35 9 32 41 32 37 191
2022/20231.675 122 116 35 162 78 194 27 126 699 11 83 22
2023/2024480 71 17 43 34 33 110 22 35 3 51 22 39
2024/20252.450 53 48 174 148 298 280 331 125 553 107 162 171
2025/20264.251 210 344 600 518 518 247 687 156 323 444 157 47
2026/2027360 178 146 36 0 0 0 0 0 0 0 0 0
Totale 9.906